Morrill Scholar named
The Office of Diversity and Inclusion’s Morrill Scholarship Program is pleased to announce that Shelby Newsad, a senior majoring in biochemistry, has been named a semi-finalist for an international post-graduate Fulbright Scholarship.
If selected, Shelby will be awarded a Fulbright Study/Research Grant to work in the lab of Dr. Alexander Titz at the Helmholtz Institute for Pharmaceutical Research in Saarland, Germany. The institute is concerned with Pseudomonas aeruginosa, the primary pathogen of cystic fibrosis patients and a frequent hospital-acquired infection. P. aeruginosa is a gram-negative bacterium which is multi-resistant against antibiotics, protecting itself against the host immune system through a biofilm mode of life. In this project, Shelby will look at a recently-described protein that is involved in biofilm adherence and structural stability of P. aeruginosa. She hopes not only to characterize but to elucidate the structure of this protein, thus allowing new drug targets of this deadly pathogen.
In addition to being a Fulbright semi-finalist, Shelby has been accepted to the University of Cambridge (England) to commence a PhD in Biological Sciences.
Shelby will be notified in April 2016 if she has received her Fulbright grant.
The Fulbright Program is the flagship international educational exchange program sponsored by the U.S. government and is designed to increase mutual understanding between the people of the United States and the people of other countries. The primary source of funding for the Fulbright Program is an annual appropriation made by the U.S. Congress to the U.S. Department of State, Bureau of Educational and Cultural Affairs. Participating governments, host institutions, corporations, and foundations in foreign countries and in the United States also provide direct and indirect support. Recipients of Fulbright grants are selected on the basis of academic or professional achievement, as well as demonstrated leadership potential in their fields. The Program operates in over 160 countries worldwide.